{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-023651","form_type":"8-K","ticker":"CVV","cik":"0000766792","company_name":"CVD EQUIPMENT CORP","filed_at":"2023-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.625436+00:00","generated_at":"2026-06-11T13:25:25.107130+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CVD Equipment Q2 revenue $5.1M (-12.7% YoY); net loss $1.1M; orders $12.9M","bullets":["Q2 2023 revenue $5.1M, down 12.7% YoY; net loss $1.1M ($0.16/sh) vs loss $0.8M ($0.12) prior year.","Orders jumped to $12.9M; backlog $18.8M, up from $12.0M at March 31, 2023.","Gross margin improved to 27.4%; non-recurring charges of $0.3M from Tantaline sale and MesoScribe wind-down.","Received $8.7M in aerospace system orders and $1.8M battery nanomaterial system order.","Cash $13.0M; sold Tantaline in May, entered agreement to sell MesoScribe assets for up to $0.9M."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-023651","json":"https://secwatch.observer/filing/0001437749-23-023651.json","markdown":"https://secwatch.observer/filing/0001437749-23-023651.md","text":"https://secwatch.observer/filing/0001437749-23-023651.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/766792/000143774923023651/0001437749-23-023651-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/766792/000143774923023651/cvv20230810_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T13:25:25.107130+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"442e35c036a37b3c769a6b7a17fb9bfcb19e581d","claim":"CVD EQUIPMENT CORP reported second quarter ended June 30, 2023 results: revenue $5.1 million, net income $1.1 million, EPS $0.16 basic and diluted share.","evidence_excerpt":"course on our strategy to achieve consistent long-term profitability, with a focus on growth and return on investment.” Second Quarter 2023 Financial Performance ● Revenue of $5.1 million, down 12.7% year over year primarily due to lower system revenues ● Orders for the second quarter increased to $12.9 million driven by demand in two of our three strategic","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/766792/000143774923023651/0001437749-23-023651-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$5.1 million"},{"label":"Net income","value":"$1.1 million"},{"label":"EPS","value":"$0.16 basic and diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}